P3 Health Partners Inc.
PIIIW
NASDAQ0.01
USD
+0.00
- -
CIK
0001832511
ISIN
US7444131137
CUSIP
744413113
Return %
Stock
S&P500
1Y
14.58
19.01
3Y
-93.12
65.49
5Y
-99.21
72.21
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Aric Coffman
- Full Time Employees
- 320
- Sector
- Industrials
- Industry
- Specialty Business Services
- Address
- 2370 Corporate Circle Henderson NV United States of America 89074
- IPO Date
- Mar 6, 2026
- CIK
- 0001832511
- Website
- p3hp.org
- Similar Companies
- Business
- P3 Health Partners Inc. (NASDAQ: PIII) is a patient-centered, physician-led population health management company that supports primary care providers with value-based care coordination, administrative services, and care delivery for Medicare Advantage patients across the United States; core offerings include nurse practitioners in P3 wellness centers, care teams of registered nurses and other professionals providing preventive care coordination, care navigation, medication management, transitions of care, chronic condition management, network management, and utilization management delegation from health plans. Founded in 2015 and headquartered in Henderson, Nevada, the company operates in 24 counties across four states with an expansive network of more than 2,700 affiliated primary care providers managing thousands of at-risk members, targeting senior patients through whole-patient wellness, prevention, and full-cycle care integration with community resources. Recent developments include a December 2024 unsecured promissory note financing of up to $25 million from VBC Growth SPV for working capital, a proposed additional $30 million unsecured note with its largest shareholder announced in February 2025, over $130 million in strategic EBITDA improvement initiatives launched with benefits starting in Q4 2024, a 1-for-50 reverse stock split in April 2025, intentional network and payer rationalization reducing average at-risk membership, and expansion of its Care Enablement Model as reported in Q3 2025 results with revised full-year guidance projecting $1.400 billion to $1.450 billion in revenues and targeting profitability in 2025.